StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Vertex Europe (UK) — Dividends paid to parent by Year

Vertex Europe (UK) — Dividends paid to parent ($M) ($M)

Vertex Pharmaceuticals Vertex Europe (UK) — Dividends paid to parent: $535M in FY2025, up 7.0% from a year earlier.

Latest, FY2025
535
Period ended Dec 31, 2025
Change on a year earlier
+7.0%
500 in FY2024
History
3 years
Since FY2023
Sources
1
Vertex Pharmaceuticals (Europe) Limited (02907620)

Where the FY2025 figure comes from

“During the year, the Company distributed and paid out dividends of $535 million (2024: $500 million) to its parent.”

Source: Vertex Pharmaceuticals (Europe) Limited (02907620) ↗

Reported in UK Companies House Statutory Accounts (02907620, OCR).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedVertex Europe (UK) — Dividends paid to parent ($M) ($M)Year on yearSource
FY2025Dec 31, 2025535+7.0%Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
FY2024Dec 31, 2024500+25.0%Vertex Pharmaceuticals (Europe) Limited (02907620) ↗
FY2023Dec 31, 2023400–Vertex Pharmaceuticals (Europe) Limited (02907620) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Vertex Europe (UK) — Dividends paid to parent ($M), annual FY2023–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/uk-eur-div-paid

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.